Format

Send to

Choose Destination
See comment in PubMed Commons below
Intensive Care Med. 2010 Nov;36(11):1826-35. doi: 10.1007/s00134-010-1983-5. Epub 2010 Aug 6.

Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?

Author information

1
Pole Anesthésie Réanimation, Centre Hospitalier Universitaire d'Amiens, Université Jules Verne de Picardie, Place Victor Pauchet, 80054, Amiens Cedex, France. lorne.emmanuel@chu-amiens.fr

Abstract

PURPOSE:

Although the role of Toll-like receptors (TLRs) in bacterial infection and sepsis is well characterized, recent studies have also shown that TLR4 and TLR2 can play an important role in contributing to acute inflammatory processes and organ dysfunction in settings in which LPS or other bacterial products are not present. This review presents not only insights into pathophysiologic mechanisms that contribute to organ dysfunction and outcome in critical illness, but also direct therapeutic approaches to ameliorating such TLR-mediated responses that may potentially be of clinical benefit in critically ill patients.

METHOD:

Literature review of the role of TLR4 and TLR2 in sterile inflammation relevant to critical care medicine using PubMed search, including original papers in English from 1990 to 2010.

CONCLUSION:

There is increasing evidence that TLR4 and TLR2 are not only receptors for bacterial products, but also can be activated through other mechanisms relevant to the pathophysiology of critical illnesses. There is evidence that TLR4 and TLR2 are involved in ischemia-reperfusion injury and trauma where Gram-negative or Gram-positive bacteria are not detectible in the circulation or local organ sites, such as the lungs. In these settings TLRs can transduce other proinflammatory signals and thereby contribute to cellular activation leading to acute lung injury and other organ system dysfunction. The consequences of TLR4 and TLR2 activation through reactive oxygen species (ROS), heat shock proteins, and other non-LPS dependent mechanisms may be different from those associated with binding of the membrane component of bacteria to TLR4 or TLR2 and may produce different signatures of gene activation and release of proinflammatory mediators.

PMID:
20689929
PMCID:
PMC3090256
DOI:
10.1007/s00134-010-1983-5
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center